Elecsys HE4 Chinese Reference Value Study

计划入组 2,351 人 · 首次发布于 2012 年 11 月 30 日

NFL LONG Prospective Study

计划入组 250 人 · 首次发布于 2020 年 2 月 10 日

Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC

计划入组 600 人 · 首次发布于 2023 年 8 月 2 日

NFL-101

NFL-201

NFL-301

NFL Biosciences SAS

France

Elusys Therapeutics, Inc.

United States

SFL Pharmaceuticals Deutschland GmbH

Roche Receives CE Mark for Elecsys NfL Blood Test to Monitor Multiple Sclerosis Neuroinflammation

Roche Secures CE Mark for Automated Elecsys IGRA TB Diagnostic Test

NFL Biosciences' NFL-101 Demonstrates Significant Efficacy in Phase II Smoking Cessation Trial